TickerFactsScreenerDevelopers

MoonLake Immunotherapeutics (MLTX) — Cash & Equivalents

Annual figures by fiscal year, from SEC filings.

2020: $1.34M2021: $8.04M2022: $39.51M2023: $451.17M2024: $180.43M2025: $334.52M$334.52M
2020Cash & Equivalents (USD)2025
Fiscal YearCash & EquivalentsChange YoY
2025$334.52M+85.4%
2024$180.43M-60.0%
2023$451.17M+1042.0%
2022$39.51M+391.4%
2021$8.04M+501.7%
2020$1.34M—